Cited by 535Cancer, Hypoxia, and MetabolismMitochondrial Function and PathologyBiochemical Acid Research Studies

The DOI matches its Crossref record; 213 of the 215 references it cites were found in a registry or an index; 9 of the 205 sources its claims cite were checked for support.

Regulation and function of the mammalian tricarboxylic acid cycle

Open access
Arnold, Paige K., Finley, Lydia W.S.·2023·Journal of Biological Chemistry

Abstract

The tricarboxylic acid (TCA) cycle, otherwise known as the Krebs cycle, is a central metabolic pathway that performs the essential function of oxidizing nutrients to support cellular bioenergetics. More recently, it has become evident that TCA cycle behavior is dynamic, and products of the TCA cycle can be co-opted in cancer and other pathologic states. In this review, we revisit the TCA cycle, including its potential origins and the history of its discovery. We provide a detailed accounting of the requirements for sustained TCA cycle function and the critical regulatory nodes that can stimulate or constrain TCA cycle activity. We also discuss recent advances in our understanding of the flexibility of TCA cycle wiring and the increasingly appreciated heterogeneity in TCA cycle activity exhibited by mammalian cells. Deeper insight into how the TCA cycle can be differentially regulated and, consequently, configured in different contexts will shed light on how this pathway is primed to meet the requirements of distinct mammalian cell states.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This review revisits the mammalian tricarboxylic acid (TCA) cycle, covering its evolutionary origins, historical discovery, biochemical wiring, regulation, and context-dependent heterogeneity. It argues that TCA cycle activity is dynamic and can be rewired or co-opted in cancer, immune cells, stem cells, and other mammalian cell states.

Key findings

  • Each complete turn of the TCA cycle oxidizes acetyl-CoA, releases two CO2 molecules, generates three NADH and one FADH2, and produces one GTP or ATP; oxaloacetate (OAA) is regenerated and acts catalytically. The cycle is amphibolic, supporting both catabolism and biosynthesis.
  • Sustained TCA cycle function requires continuous acetyl-CoA supply and anaplerosis to replace intermediates lost through cataplerosis. Acetyl-CoA sources include glucose/pyruvate, circulating lactate, fatty acids, amino acids, ketone bodies, and acetate; anaplerotic routes include glutamine oxidation, pyruvate carboxylase, propionyl-CoA/succinyl-CoA, and fumarate entry.
  • TCA cycle wiring is flexible: reductive carboxylation occurs under hypoxia or impaired respiration; reverse SDH reduces fumarate to succinate when ETC is inhibited; reverse citrate synthase can occur in SDH deficiency; and the citrate–malate shuttle can act as a noncanonical TCA cycle in cancer cells and embryonic stem cells.
  • Regulation occurs through allosteric control (NADH inhibits CS, IDH, and OGDH; ATP/ADP inhibits IDH; succinyl-CoA inhibits CS and OGDH; OAA inhibits SDH), covalent PDHC phosphorylation by PDKs/PDPs, and ion-mediated control (Ca2+ activates IDH, OGDH, and PDHC; iron affects aconitase). TCA metabolites also influence chromatin and cell fate, with oncometabolites succinate, fumarate, and 2HG inhibiting αKG-dependent dioxygenases. Reported examples include branched-chain amino acid catabolism accounting for almost a third of cellular acetyl-CoA pools in differentiated adipocytes, up to half of intramitochondrial acetyl-CoA derived from circulating acetate in glioblastoma tumors, and 2HG accumulating to millimolar levels in CD8+ T cells.

Methods

  • Narrative review; no primary experimental data are presented.
  • Synthesizes historical and recent literature on TCA cycle evolution, discovery, wiring, regulation, and heterogeneity across mammalian cell types and disease contexts.
  • Main analysis is conceptual and integrative, with figures summarizing the oxidative TCA cycle, reductive TCA cycle, inputs/outputs, electron shuttles, PDHC regulation, and chromatin regulation.

Limitations

  • The paper does not include a formal limitations section. It states many open questions and future directions, including how TCA cycle diversity is achieved, the extent to which cells transit between metabolic states, how intermediates are partitioned across compartments, what signals control anaplerotic fluxes, and whether core TCA cycle enzymes are regulated by phosphorylation.
  • Evident from the text: as a narrative review, it lacks systematic search criteria or quantitative synthesis, so its conclusions depend on the selected cited literature.
  • The authors declare a conflict of interest: they are authors on patent applications covering links between cellular metabolism and cell fate control.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.jbc.2022.102838

Cites

213 of 214 references verified1 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Overview of the tricarboxylic acid (TCA) cycle and electron transport chain (ETC). The TCA cycle starts when the two-carbon molecule acetyl-CoA combines with four-carbon oxaloacetate to form citrate, a reaction catalyzed by citrate synthase (CS). Citrate is then converted to isocitrate by aconitase 2 (ACO2). Isocitrate is decarboxylated to alpha-ketoglutarate (αKG) in an NAD+-dependent manner by isocitrate dehydrogenase 3 (IDH3) or in an NADP+-dependent manner by isocitrate dehydrogenase 2 (IDH2), releasing carbon dioxide (CO2). αKG undergoes decarboxylation to succinyl-CoA via the oxoglutarate dehydrogenase complex (OGDH), producing NADH and releasing CO2. Succinyl-CoA is then converted to succinate by succinyl-CoA synthetase (SCS). This is the only substrate-level phosphorylation step in the TCA cycle, as it is coupled to the generation of GTP or ATP. Succinate is converted to fumarate by succinate dehydrogenase (SDH) complex, a multisubunit enzyme complex that participates in both the TCA cycle and the electron transport chain (ETC). SDH reduces FAD to FADH2, which donates its electrons to complex II. Fumarate is converted to malate by fumarate hydratase (FH). Malate dehydrogenase 2 (MDH2) converts malate to oxaloacetate in an NAD+-dependent manner, regenerating the starting molecule and supporting the next turn of the cycle. Note: most TCA cycle reactions are reversible. Substrate oxidation reactions are coupled to reduction of electron carriers NAD+ and FAD: each complete turn of the TCA cycle generates three NADH and one FADH2 molecules, which donate their electrons to complex I and complex II, respectively. These reducing equivalents are reoxidized upon donating their electrons to the ETC, supporting continued TCA cycle activity. Electrons donated to complexes I and II are transferred to ubiquinone (Q), reducing it to ubiquinol (QH2). Ubiquinol is reoxidized to ubiquinone upon passing its electrons to complex III, which transfers electrons to cytochrome C (Cyt C). Cyt C passes its electrons onto complex IV, which then transfers its electrons to the terminal electron acceptor, oxygen (O2), forming water (H2O). As electrons are transferred through the ETC and eventually onto oxygen, complexes I, III, and IV pump protons across the inner mitochondrial membrane. This proton pumping establishes a proton gradient that is used by complex V, or ATP synthase, to generate ATP from ADP, a process known as oxidative phosphorylation (OXPHOS). TCA cycle enzymes are colored in orange; SDH is colored blue and orange because it participates in both the TCA cycle and the ETC. Reducing equivalents are shown in pink.
Figure 1 Overview of the tricarboxylic acid (TCA) cycle and electron transport chain (ETC). The TCA cycle starts when the two-carbon molecule acetyl-CoA combines with four-carbon oxaloacetate to form citrate, a reaction catalyzed by citrate synthase (CS). Citrate is then converted to isocitrate by aconitase 2 (ACO2). Isocitrate is decarboxylated to alpha-ketoglutarate (αKG) in an NAD+-dependent manner by isocitrate dehydrogenase 3 (IDH3) or in an NADP+-dependent manner by isocitrate dehydrogenase 2 (IDH2), releasing carbon dioxide (CO2). αKG undergoes decarboxylation to succinyl-CoA via the oxoglutarate dehydrogenase complex (OGDH), producing NADH and releasing CO2. Succinyl-CoA is then converted to succinate by succinyl-CoA synthetase (SCS). This is the only substrate-level phosphorylation step in the TCA cycle, as it is coupled to the generation of GTP or ATP. Succinate is converted to fumarate by succinate dehydrogenase (SDH) complex, a multisubunit enzyme complex that participates in both the TCA cycle and the electron transport chain (ETC). SDH reduces FAD to FADH2, which donates its electrons to complex II. Fumarate is converted to malate by fumarate hydratase (FH). Malate dehydrogenase 2 (MDH2) converts malate to oxaloacetate in an NAD+-dependent manner, regenerating the starting molecule and supporting the next turn of the cycle. Note: most TCA cycle reactions are reversible. Substrate oxidation reactions are coupled to reduction of electron carriers NAD+ and FAD: each complete turn of the TCA cycle generates three NADH and one FADH2 molecules, which donate their electrons to complex I and complex II, respectively. These reducing equivalents are reoxidized upon donating their electrons to the ETC, supporting continued TCA cycle activity. Electrons donated to complexes I and II are transferred to ubiquinone (Q), reducing it to ubiquinol (QH2). Ubiquinol is reoxidized to ubiquinone upon passing its electrons to complex III, which transfers electrons to cytochrome C (Cyt C). Cyt C passes its electrons onto complex IV, which then transfers its electrons to the terminal electron acceptor, oxygen (O2), forming water (H2O). As electrons are transferred through the ETC and eventually onto oxygen, complexes I, III, and IV pump protons across the inner mitochondrial membrane. This proton pumping establishes a proton gradient that is used by complex V, or ATP synthase, to generate ATP from ADP, a process known as oxidative phosphorylation (OXPHOS). TCA cycle enzymes are colored in orange; SDH is colored blue and orange because it participates in both the TCA cycle and the ETC. Reducing equivalents are shown in pink.CC BY · PubMed Central
Figure 2 The reductive tricarboxylic acid (TCA) cycle. A simplified schematic depicting the reductive TCA cycle or reverse Krebs cycle. Most reactions of this cycle are the same as those of the oxidative TCA cycle but in reverse and are catalyzed by similar enzymes. The major exceptions include (1) cleavage of citrate to form oxaloacetate and acetyl-CoA and (2) the production of alpha-ketoglutarate (αKG) from succinyl-CoA. Citrate cleavage requires ATP and is carried out by ATP-citrate lyase (ACL) or the related citryl-CoA lyase and citryl-CoA synthase enzymes. Conversion of succinyl-CoA to αKG, mediated by αKG synthase, is highly energetically unfavorable and thus requires a strong reducing agent in the form of reduced ferredoxin (Ferredoxinred). While the oxidative TCA cycle combusts carbon and produces reducing equivalents that drive ATP synthesis, the reductive TCA cycle consumes ATP and reducing equivalents to assimilate carbon and produce acetyl-CoA. Reducing equivalents are shown in pink.
Figure 2 The reductive tricarboxylic acid (TCA) cycle. A simplified schematic depicting the reductive TCA cycle or reverse Krebs cycle. Most reactions of this cycle are the same as those of the oxidative TCA cycle but in reverse and are catalyzed by similar enzymes. The major exceptions include (1) cleavage of citrate to form oxaloacetate and acetyl-CoA and (2) the production of alpha-ketoglutarate (αKG) from succinyl-CoA. Citrate cleavage requires ATP and is carried out by ATP-citrate lyase (ACL) or the related citryl-CoA lyase and citryl-CoA synthase enzymes. Conversion of succinyl-CoA to αKG, mediated by αKG synthase, is highly energetically unfavorable and thus requires a strong reducing agent in the form of reduced ferredoxin (Ferredoxinred). While the oxidative TCA cycle combusts carbon and produces reducing equivalents that drive ATP synthesis, the reductive TCA cycle consumes ATP and reducing equivalents to assimilate carbon and produce acetyl-CoA. Reducing equivalents are shown in pink.CC BY · PubMed Central
Figure 3 Outputs and inputs into the tricarboxylic acid (TCA) cycle. A functioning TCA cycle requires a continuous pool of acetyl-CoA and supply of TCA cycle intermediates that can be used to synthesize oxaloacetate. A, removal of TCA cycle intermediates (“cataplerosis”) occurs at multiple steps of the cycle to supply precursors for biosynthetic processes or feed into other metabolic pathways. B, replacement of TCA cycle intermediates (“anaplerosis”) is required to support continuous production of oxaloacetate. Sources of anaplerosis are shown in this panel. Several pathways either produce acetyl-CoA directly or produce pyruvate, an indirect source of acetyl-CoA through the activity of the pyruvate dehydrogenase complex.
Figure 3 Outputs and inputs into the tricarboxylic acid (TCA) cycle. A functioning TCA cycle requires a continuous pool of acetyl-CoA and supply of TCA cycle intermediates that can be used to synthesize oxaloacetate. A, removal of TCA cycle intermediates (“cataplerosis”) occurs at multiple steps of the cycle to supply precursors for biosynthetic processes or feed into other metabolic pathways. B, replacement of TCA cycle intermediates (“anaplerosis”) is required to support continuous production of oxaloacetate. Sources of anaplerosis are shown in this panel. Several pathways either produce acetyl-CoA directly or produce pyruvate, an indirect source of acetyl-CoA through the activity of the pyruvate dehydrogenase complex.CC BY · PubMed Central
Figure 4 Electron shuttles that intersect with the tricarboxylic acid (TCA) cycle or electron transport chain (ETC).A, in the glycerol 3-phosphate shuttle, the conversion of dihydroxyacetone phosphate into glycerol 3-phosphate by cytosolic glycerol 3-phosphate dehydrogenase 1 (GPD1) regenerates cytosolic NAD+ in the cytoplasm to support continued glycolysis. Glycerol 3-phosphate is subsequently converted back to dihydroxyacetone phosphate on the outer side of the inner mitochondrial membrane by mitochondrial glycerol 3-phosphate dehydrogenase 2 (GPD2), which is coupled with the conversion of FAD to FADH2. FADH2 donates electrons to ubiquinone (Q), reducing it to ubiquinol (QH2) that passes its electrons to complex III of the ETC. B, in the malate–aspartate shuttle (left), the TCA cycle intermediate oxaloacetate (OAA) and glutamate undergo transamination by glutamic-oxaloacetic transaminase 2 (GOT2), producing alpha-ketoglutarate (αKG) and aspartate. Mitochondrial aspartate is exported to the cytoplasm by the mitochondrial transporter proteins SLC25A12 or SLC25A13, and this efflux is concomitant with import of glutamate and a proton. Cytosolic aspartate is consumed by the cytosolic transaminase GOT1, converting αKG to glutamate and producing OAA. Cytosolic OAA is converted to malate by malate dehydrogenase 1 (MDH1), which is coupled with oxidation of NADH to NAD+, supporting glycolysis by regenerating NAD+ required for GAPDH. MDH1-generated malate is then reimported into mitochondria via the transporter SLC25A11, which is coupled with efflux of mitochondrial αKG. MDH2 converts malate to OAA, thereby reducing NAD+ to NADH and completing the cycle. In the citrate–malate shuttle (right), the citrate–malate antiporter SLC25A1 exports citrate to the cytosol, where it undergoes energy-dependent cleavage by ATP-citrate lyase (ACL), liberating acetyl-CoA and OAA. Conversion of OAA to malate by MDH1 supports NADH oxidation to NAD+, and this malate is imported into mitochondria in exchange for citrate by SLC25A1. In the mitochondria, malate is oxidized to OAA by MDH2, completing the shuttling of NADH into the mitochondrion.
Figure 4 Electron shuttles that intersect with the tricarboxylic acid (TCA) cycle or electron transport chain (ETC).A, in the glycerol 3-phosphate shuttle, the conversion of dihydroxyacetone phosphate into glycerol 3-phosphate by cytosolic glycerol 3-phosphate dehydrogenase 1 (GPD1) regenerates cytosolic NAD+ in the cytoplasm to support continued glycolysis. Glycerol 3-phosphate is subsequently converted back to dihydroxyacetone phosphate on the outer side of the inner mitochondrial membrane by mitochondrial glycerol 3-phosphate dehydrogenase 2 (GPD2), which is coupled with the conversion of FAD to FADH2. FADH2 donates electrons to ubiquinone (Q), reducing it to ubiquinol (QH2) that passes its electrons to complex III of the ETC. B, in the malate–aspartate shuttle (left), the TCA cycle intermediate oxaloacetate (OAA) and glutamate undergo transamination by glutamic-oxaloacetic transaminase 2 (GOT2), producing alpha-ketoglutarate (αKG) and aspartate. Mitochondrial aspartate is exported to the cytoplasm by the mitochondrial transporter proteins SLC25A12 or SLC25A13, and this efflux is concomitant with import of glutamate and a proton. Cytosolic aspartate is consumed by the cytosolic transaminase GOT1, converting αKG to glutamate and producing OAA. Cytosolic OAA is converted to malate by malate dehydrogenase 1 (MDH1), which is coupled with oxidation of NADH to NAD+, supporting glycolysis by regenerating NAD+ required for GAPDH. MDH1-generated malate is then reimported into mitochondria via the transporter SLC25A11, which is coupled with efflux of mitochondrial αKG. MDH2 converts malate to OAA, thereby reducing NAD+ to NADH and completing the cycle. In the citrate–malate shuttle (right), the citrate–malate antiporter SLC25A1 exports citrate to the cytosol, where it undergoes energy-dependent cleavage by ATP-citrate lyase (ACL), liberating acetyl-CoA and OAA. Conversion of OAA to malate by MDH1 supports NADH oxidation to NAD+, and this malate is imported into mitochondria in exchange for citrate by SLC25A1. In the mitochondria, malate is oxidized to OAA by MDH2, completing the shuttling of NADH into the mitochondrion.CC BY · PubMed Central
Figure 5 Allosteric and covalent regulation of the pyruvate dehydrogenase (PDHC) complex. The PDHC catalyzes the irreversible decarboxylation of pyruvate to acetyl-CoA, releasing CO2 and transferring electrons to NAD+ to form NADH. The PDHC utilizes multiple coenzymes, including coenzyme A (CoA-SH), during its multistep reaction. The complex is activated by increased levels of ADP, NAD+, CoA-SH, and its substrate pyruvate. Conversely, the PDHC is allosterically inhibited by high levels of ATP, NADH, and its product acetyl-CoA. Phosphorylation of any of three serine residues on the PDHC by pyruvate dehydrogenase kinases (PDKs) inactivates the complex. The PDKs are activated by high levels of ATP, NADH, and acetyl-CoA, reinforcing the shutdown of PDHC flux under these high-energy conditions. Reciprocally, the PDKs are inhibited by ADP, NAD+, CoA-SH, and pyruvate. The inhibitory phosphorylation of PDHC is reversible and can be removed by the pyruvate dehydrogenase phosphatases (PDPs), which are activated by mitochondrial calcium (Ca2+).
Figure 5 Allosteric and covalent regulation of the pyruvate dehydrogenase (PDHC) complex. The PDHC catalyzes the irreversible decarboxylation of pyruvate to acetyl-CoA, releasing CO2 and transferring electrons to NAD+ to form NADH. The PDHC utilizes multiple coenzymes, including coenzyme A (CoA-SH), during its multistep reaction. The complex is activated by increased levels of ADP, NAD+, CoA-SH, and its substrate pyruvate. Conversely, the PDHC is allosterically inhibited by high levels of ATP, NADH, and its product acetyl-CoA. Phosphorylation of any of three serine residues on the PDHC by pyruvate dehydrogenase kinases (PDKs) inactivates the complex. The PDKs are activated by high levels of ATP, NADH, and acetyl-CoA, reinforcing the shutdown of PDHC flux under these high-energy conditions. Reciprocally, the PDKs are inhibited by ADP, NAD+, CoA-SH, and pyruvate. The inhibitory phosphorylation of PDHC is reversible and can be removed by the pyruvate dehydrogenase phosphatases (PDPs), which are activated by mitochondrial calcium (Ca2+).CC BY · PubMed Central
Figure 6 Regulation of chromatin by tricarboxylic acid (TCA) cycle–associated metabolites. Certain TCA cycle–derived metabolites (left) control the regulation of chromatin and, in turn, gene expression. Histone acetyltransferases (HAT) transfer acetyl groups from acetyl-CoA to histones, thereby altering chromatin accessibility. Histone deacetylases (HDACs) remove acetyl groups from histones and generate acetate as a product. Methylation on histones and DNA is deposited by histone lysine methyltransferases (KMTs) and DNA methyltransferases (DNMTs), respectively. DNMT and KMT add methyl groups by catalyzing the transfer of a methyl group from S-adenosyl methionine (SAM), producing S-adenosyl homocysteine (SAH). Alpha-ketoglutarate (αKG)-dependent dioxygenases regulate the demethylation of histones and nucleic acids. Jumonji C-domain–containing histone demethylases (JHDMs) and ten–eleven translocation (TET) DNA methylcytosine dioxygenases, which remove repressive histone marks and 5-methylcytosine, respectively, require αKG as an obligate cosubstrate and are competitively inhibited by succinate, fumarate, and 2-hydroxyglutarate (2HG). mRNA methylation is controlled by the RNA methyltransferases and αKG-dependent dioxygenases FTO and ALKBH5, which like all αKG-dependent dioxygenases are stimulated by αKG and repressed by succinate, fumarate, and 2HG. Histone and RNA demethylation produce formaldehyde as a byproduct.
Figure 6 Regulation of chromatin by tricarboxylic acid (TCA) cycle–associated metabolites. Certain TCA cycle–derived metabolites (left) control the regulation of chromatin and, in turn, gene expression. Histone acetyltransferases (HAT) transfer acetyl groups from acetyl-CoA to histones, thereby altering chromatin accessibility. Histone deacetylases (HDACs) remove acetyl groups from histones and generate acetate as a product. Methylation on histones and DNA is deposited by histone lysine methyltransferases (KMTs) and DNA methyltransferases (DNMTs), respectively. DNMT and KMT add methyl groups by catalyzing the transfer of a methyl group from S-adenosyl methionine (SAM), producing S-adenosyl homocysteine (SAH). Alpha-ketoglutarate (αKG)-dependent dioxygenases regulate the demethylation of histones and nucleic acids. Jumonji C-domain–containing histone demethylases (JHDMs) and ten–eleven translocation (TET) DNA methylcytosine dioxygenases, which remove repressive histone marks and 5-methylcytosine, respectively, require αKG as an obligate cosubstrate and are competitively inhibited by succinate, fumarate, and 2-hydroxyglutarate (2HG). mRNA methylation is controlled by the RNA methyltransferases and αKG-dependent dioxygenases FTO and ALKBH5, which like all αKG-dependent dioxygenases are stimulated by αKG and repressed by succinate, fumarate, and 2HG. Histone and RNA demethylation produce formaldehyde as a byproduct.CC BY · PubMed Central

Verification

Claims the paper makes

132 Not checked yet · 26 Own interpretation · 13 No basis given · 3 Supported · 3 Partly supported · 1 Own result · accuracy not yet measured

Verify all 196 references — free account

Show all 99 claims

  • Probably not a substantial claim. 15
  • It may state two separate claims as one. 73
79 of 79
  • The paper relies on this without support.

    Mutations that impair FH and SDH activity are associated with pathologic accumulation of fumarate and succinate, respectively.

    “Mutations that impair fumarate hydratase (FH) and SDH activity are associated with pathologic accumulation of substrates fumarate and succinate, respectively.”
  • The paper relies on this without support.

    Acetyl-CoA itself cannot transit across the mitochondrial membrane.

    “Acetyl-CoA itself cannot transit across the mitochondrial membrane.”
  • The paper relies on this without support.

    Most mammalian cells growing in culture rely on both glucose- and glutamine-derived carbon to fuel the TCA cycle.

    “Most mammalian cells growing in culture rely on both glucose- and glutamine-derived carbon to fuel the TCA cycle.”
  • The paper relies on this without support.

    Most cultured cell lines require glutamine supplementation to support cell survival and proliferation.

    “While most cultured cell lines require glutamine supplementation to support cell survival and proliferation, naïve mouse ESCs can grow in the absence of exogenous glutamine.”
  • The paper relies on this without support.

    Adult tissue stem cells maintain organ homeostasis by balancing self-renewal and differentiation into mature cell types.

    “Adult tissue stem cells maintain organ homeostasis by balancing self-renewal and differentiation into mature cell types.”
  • The paper relies on this without support.

    Pluripotency is a state that exists only transiently during early mammalian development.

    “While pluripotency, or the ability to give rise to all embryonic germ layers, is a state that exists only transiently during early mammalian development, it can be modeled indefinitely in vitro using ESCs derived from the inner cell mass of preimplantation blastocysts (210).”
  • The paper relies on this without support.

    Mouse and human ESCs can be cultured under conditions that drive a spectrum of pluripotent states.

    “Mouse and human ESCs can be cultured under conditions that drive a spectrum of pluripotent states, ranging from those that closely mimic the preimplantation state (otherwise known as the “naïve” state) to those that resemble the postimplantation epiblast.”
  • The paper relies on this without support.

    The TCA cycle provides another critical input to chromatin regulation in the form of acetyl-CoA.

    “The TCA cycle provides another critical input to chromatin regulation in the form of acetyl-CoA.”
  • The paper relies on this without support.

    TCA cycle metabolites can function as messengers facilitating interorgan crosstalk.

    “Beyond their intracellular roles, TCA cycle metabolites can also function as messengers facilitating interorgan crosstalk.”
  • The paper relies on this without support.

    Succinate represents the most established example of a TCA cycle intermediate that serves as a paracrine signal.

    “To date, succinate represents the most established example of a TCA cycle intermediate that serves as a paracrine signal.”
10 of 10

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 215 references

Research works printed but not linked: 3

  1. Kornberg, 1966, Anapleroic sequences and their role in metabolism, Essays Biochem., 2, 1
  2. Martius, 1937, Physiological breakdown of citric acid, Prelim. Z. Physiol. Chem., 246, 1
  3. Warburg, 1924, Ueber den stoffwechsel der tumoren, Biochem. Z., 152, 319

Cited by

Sorted by citations

See all 535

Metadata

Authors
Arnold, P. K., & Finley, L. W. S.
Affiliations
Memorial Sloan Kettering Cancer Center (US)
Corresponding author
Finley, Lydia W.S.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2023-02
Volume
299
Issue
2
Pages
102838
ISSN
0021-9258 (ISSN-L)
OpenAlex
W4312221298
Cited by
535
References
215
Citations by year
2026: 172 · 2025: 209 · 2024: 120 · 2023: 33
FWCI
11.17
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Cancer Institute (P30CA008748, R37CA252305)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (F31HD098824)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Biochemical Acid Research Studies
Keywords
TCA cycle, cellular bioenergetics, nutrient oxidation, cancer metabolism, mammalian cells, cell state heterogeneity
MeSH terms
Animals, Citric Acid Cycle, Energy Metabolism, Mammals

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review